Viewing Study NCT03538392

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-01-17 @ 10:51 AM
Study NCT ID: NCT03538392
Status: WITHDRAWN
Last Update Posted: 2020-04-10
First Post: 2018-04-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
Sponsor: Cagent Vascular LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral Arterial Disease View
None Arterio-venous Fistula View
None Arteriovenous Graft View
Keywords: